Axsome Therapeutics, Inc. (AXSM)
206.89
-1.46
(-0.70%)
USD |
NASDAQ |
Sep 04, 16:00
206.96
+0.07
(+0.03%)
After-Hours: 20:00
Axsome Therapeutics Cash and Short Term Investments (Annual) : 322.93M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 322.93M |
| December 31, 2024 | 315.35M |
| December 31, 2023 | 386.19M |
| December 31, 2022 | 200.84M |
| December 31, 2021 | 86.47M |
| December 31, 2020 | 183.88M |
| December 31, 2019 | 219.97M |
| Date | Value |
|---|---|
| December 31, 2018 | 13.97M |
| December 31, 2017 | 34.02M |
| December 31, 2016 | 36.62M |
| December 31, 2015 | 48.04M |
| December 31, 2014 | 2.618M |
| December 31, 2013 | 2.088M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Eli Lilly & Co. | 7.268B |
| Liquidia Corp. | 190.68M |
| Filana Therapeutics, Inc. | 95.50M |
| CorMedix, Inc. | 149.19M |
| Eloxx Pharmaceuticals, Inc. | 4.791M |